DUBLIN and PHILADELPHIA -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that its subsidiary Shire Pharmaceuticals Inc. received a ruling from the FDA on its Citizen's Petition relating to PentasaThe ruling granted-in-part and denied-in-part the re

read more>>

CHICAGO -- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced plans to seek additional Adv

read more>>

RALEIGH -- North Carolina will receive about $569,000 from pharmaceutical manufacturer InterMune Inc. as part of a $36.9 million settlement to resolve allegations that the company unlawfully marketed its drug Actimmune for unapproved usesThe Food and Drug Administration approved Actimmune to treat

read more>>

Leiden -- to-BBB, the Dutch brain drug delivery company, announces that the Food and Drug Administration (FDA) has granted orphan drug designation for to-BBB’s brain cancer lead product 2B3-101As a proprietary brain-targeted version of the marketed product Caelyx®/Doxil® (PEG-liposom

read more>>

Roche Holding AG again failed to win the backing of the U.K.’s health-cost panel for use of its Avastin drug in patients with colorectal cancer that has spreadThe medicine isn’t cost-effective for the tumors when used with the chemotherapy drugs oxaliplatin and either 5- fluorouracil o

read more>>

SAN DIEGO -- The Trudeau family is back to their normal routine after 7-year-old Effraim and 10-year-old Shanice came down with whooping cough, also known as pertussis“She would cough so hard she would literally throw up,“ mother Lyla Trudeau saidThe illness, now at epidemic levels in

read more>>

DEERFIELD, Ill. -- Baxter International Inc. (NYSE: BAX) today announced a definitive agreement with Kamada Ltd. for exclusive commercial rights to GLASSIA™ [Alpha 1-Proteinase Inhibitor (Human)], the first and only liquid alpha1-proteinase inhibitor, in the United States, Australia, New GL

read more>>

NASHVILLE, Tenn. -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced the U.S. Food and Drug Administration (FDA) has extended its review of the supplemental new drug application (sNDA) for the use of Acetadote® (acetylcysteine) Injection in patients with non-acetaminophen acute

read more>>

PRINCETON, N.J. -- Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company, announced today that it has been awarded a three year $1.2 million clinical research grant by the Office of Orphan Products Development (OOPD) of the U.S. Food and Th

read more>>

CAMBRIDGE, Mass. -- Genzyme Corporation announced today that the two-year follow-up results from the phase 2 clinical trial of its investigational therapy known as eliglustat tartrate have been accepted for publication in the journal BloodThe results have been pre-published on the journal's websit

read more>>